Edward Christopher Dee: The need to match advances in radiotherapy for haematological cancers
Edward Christopher Dee, Resident Physician in Radiation Oncology at Memorial Sloan Kettering Cancer Center, shared a post on X about a recent paper titled “Radiotherapy for haematological malignancies” published in The Lancet Hematology.
Authors: Edward Christopher Dee, James Fan Wu, Erin Jay Feliciano, Luisa Jacomina, Joachim Yahalom
“In The Lancet Hematology we discuss the need to match advances in radiotherapy for haematological cancers with efforts to improve access globally.”
James Wu, Haematology/Oncology Fellow at the Medical College of Wisconsin, shared this post, adding:
“In The Lancet Hematology we discuss the need for basic access to radiotherapy for haematological cancers in many resource-limited countries globally and the need to develop radiation infrastructure in those locations.”
Sources: Edward Christopher Dee/X and James Wu/X
More posts featuring Edward Christopher Dee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023